OmniComm Systems has unveiled new TrialMaster version 4.1.2 product, featuring dynamic monitoring functionality.
Dynamic monitoring feature allows pharmaceutical organizations, who conduct clinical trials, to reduce monitoring costs.
The new feature also allows customers to control how much of the data in a given trial needs to be verified against source documents such as specifying that half the patients should have full monitoring and half should be monitored for critical variables only.
OmniComm Systems development senior vice president Keith Howells said TrialMaster already offers the intuitive electronic data capture product, providing sites an unequalled level of interactivity.
"This new release provides tremendous additional benefits to the sponsor companies, notably allowing them to implement risk-based monitoring plans and thus drive down costs without impacting quality," Howells added.
"We are looking forward to a speedy adoption of these new capabilities."
